Oppenheimer Starts (SQNM), (GNOM), (CPHD) at Outperform, (MYGN), (AFFX), (GPRO), (PACB) at Perform

Article Stock Quotes (7) Comments (0)

In the Medical Equipment and Supplies group this evening, an analyst at Oppenheimer has initiated coverage on a number of stocks:

• Sequenom (Nasdaq: SQNM) with an Outperform rating and a $9 price target
  
• Complete Genomics (Nasdaq: GNOM) with an Outperform rating and a $13 price target
  
• Cepheid (Nasdaq: CPHD) with an Outperform rating and a $33 price target
  
• Myriad Genetics (Nasdaq: MYGN) with a Perform rating and a $22 price target
  
• Affymetrix (Nasdaq: AFFX) with a Perform rating
  
• Gen-Probe (Nasdaq: GPRO) with a Perform rating and a $71 price target
  
• Pacific Biosciences (Nasdaq: PACB) with a Perform rating and a $15 price target

Check out our Ratings Insider portal to get the most comprehensive and up-to-date analyst coverage on the Street.

---

Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW

---

*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here

---

---

You May Also Be Interested In

• Deutsche Bank Starts Kodiak Oil & Gas (KOG) at Hold
• Topeka Capital Starts InvenSense (INVN) at Buy
• UPDATE: MKM Partners Downgrades Alkermes (ALKS) to Sell

Create E-mail Alert Related Categories

New Coverage

Add Your Comment

Name

Subject

Body

Share on Facebook

Verification
can't see the text?
click here to refresh the image.
what's this?